Skip to content

Microbot Medical MBOT Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
Medtronic logo
MedtronicMDT
ITG
Integer HoldingsITGR
Stereotaxis logo
StereotaxisSTXS
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×

Profitability

See full
Operating margin25,292.9%
Net margin-3,669.9%
FCF margin-852.8%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's common stock, shares issued (in shares)?
Microbot Medical (MBOT) reported common stock, shares issued (in shares) of $67.16M in Q1 2026.
How has Microbot Medical's common stock, shares issued (in shares) changed year-over-year?
Microbot Medical's common stock, shares issued (in shares) increased by 93.3% year-over-year, from $34.74M to $67.16M.
What is the long-term trend for Microbot Medical's common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), Microbot Medical's common stock, shares issued (in shares) has grown at a 56.7% compound annual growth rate (CAGR), from $7.11M to $67.16M.